skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare
Read Answer Asked by sam on January 13, 2026
Q: I have held Savaria for several years now, and it has performed steadily, but has lagged in growth compared to many of my other holdings. I am wondering if it might be more prudent to consider adding to my positions in either ISRG or ABBV, or perhaps consider another company with stronger growth prospects.

My overall exposure to health care (I deem SIS to be a health care-related company) is roughly 7%, and SIS makes up about 1% (was larger initially, but grew less than portfolio over time). If a lower exposure to health care is still tolerable within a portfolio attempting to maintain diversification, are there another positions outside of the health care space that might be prudent for me to consider? Thanks so much, and I look forward to your response.
Read Answer Asked by Domenic on January 02, 2026
Q: Trying to decide whether to keep SIS or look for something with a greater return potential. When I look at the profile, (evening Dec 18), I see that it is trading at a P/E of 25.31 which seems to be based on earnings of .86, which is very close to mathing out at the share price shown of $22.25.
I also see that the current consensus estimate for EPS in 2026 is 1.37. If SIS trades at a similar P/E in Dec 2026, as it is now, 25.31, then that would give a potential share price of $34.67, approximately 56% above the current price. I see that target prices are $26-$30. Even at $30, that would make the P/E in Dec 2026 about 21; below where it is now. So, is SIS over valued now or are the estimates too low and this should be kept or bought? The high and low P/E shown in the data are very far apart so not really applicable.

An interesting note to add is that I asked Google AI for the P/E in the last 5 years and it shows the following for Dec of each of the years shown:
2020-27.4
2021-102.7 Covid outlier I guess
2022-25.5
2023-26.2
2024-29.1
2025-25.4

Sorry for the length here but don't know how else to explain my predicament...

Was going to make this public but didn't because of length- feel free to change the status if you wish.
Read Answer Asked by Robert on December 22, 2025
Q: NRXS Can you give me you opinion on this stock. Do you it has potential from current prices?
Read Answer Asked by Imtiaz on December 22, 2025
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!